Published on November 24, 2014

Indian government is bringing up new policies to revive the pale and weak pharma industries. The government is in mood to provide full lease to PSU to revive their heavy losses. The government is focusing on making the government units self-reliant and profit earning. The government has made a proposal to improve the financial status of companies and its employees who have been rundown of salaries since last six months. Again the government is taking strict steps towards the drug pricing policies of the country. Again the focus has been towards manufacturing of low costing of drugs.

Indian pharma industries have been expanding its business in various countries around the world such as Latin America. Mexico and Brazil are the two major markets for pharma industry. The pharma industry has been visiting regional markets of these countries. The well known companies of India that are doing well over there are Dr. Reddy’s Laboratories, Glenmark, Lupin, Nacto Pharma and Cipla.

Indian government is focusing on industry and user friendly pharma drug policy. The policy will provide the recommendations to Prime Minister’s office. Policy is about providing the concessions to the stakeholders and will put growth on trajectory.